Project Number PCTR-15-330495 Agency/Funding Organization Alzheimer's Association Funding Year 2015 View Full Project Details for Trial of Oxaloacetate in Alzheimer’s Disease (TOAD) Study Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator SWERDLOW, RUSSELL H Principal Investigator First Name RUSSELL Principal Investigator Last Name SWERDLOW Awardee Organization UNIVERSITY OF KANSAS MEDICAL CENTER Awardee State Kansas Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2015: PCT RFA FY Overall Cost $596,826 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Snyder, Heather hsnyder@alz.org
